About us

About Euro Rare Diseases

C2p Forum is excited to announce the European Congress on Rare Diseases and Orphan Drugs, set to take place on November 17-18, 2025, in Rome, Italy. This two-day event aims to bring together researchers, industry experts, stakeholders, and advocates from around the world to discuss the latest advancements, challenges, and opportunities in the field of rare diseases and orphan drugs. The conference’s main objective is to promote awareness, encourage collaboration, and accelerate efforts to address the unique challenges faced by individuals impacted by rare diseases.

Euro Rare Diseases 2025 will be an excellent venue for exchanging new findings and ideas among a wide range of experts involved in rare disease research, drug development, patient care, advocacy, and policy formulation. The event will feature keynote presentations, plenary sessions, panel discussions, workshops, and networking opportunities. Attendees will also have the chance to engage with exhibits showcasing the latest breakthroughs in rare disease research, diagnostics, and treatments.

Altogether Rare Diseases and Orphan Drugs 2025 is a key event focused on advancing research, encouraging innovation, and enhancing the well-being of people living with rare diseases.

Join us in Rome for the European Congress on Rare Diseases and Orphan Drugs, and be part of a transformative experience that will drive forward the frontiers of rare diseases and contribute to global health advancements. Register now to secure your place at this landmark event.

Why to Attend

  • Stay informed on cutting-edge research, diagnostics, and treatment developments in the rare disease landscape.
  • Enhance your professional practice through expert-led sessions focusing on real-world challenges and innovative solutions.
  • Engage with top researchers, clinicians, industry leaders, patient advocates, and policymakers from around the world.
  • Explore new drug development strategies, targeted therapies, and breakthrough medical technologies.
  • Participate in sessions designed to deepen your understanding of rare disease mechanisms, care models, and regulatory pathways.
  • Present your research or projects and help shape the future direction of rare disease care and orphan drug innovation.

Who Can Attend

Academic experts
Researchers
Healthcare professionals
Pharmaceutical Professionals
Regulators & Policymakers
Patient advocates
Industrial Stakeholders
Market Access Consultants
Rare Disease Community
Biotechnology Experts